" class="no-js "lang="en-US"> Industry News Archives - Page 52 of 151 - Medtech Alert
Tuesday, October 07, 2025

Sort by:

Date

Top Post

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]

Sonrava Health Enters Strategic Alliance with FCL Dental, Owner of One of the Nation’s Largest Independent Dental Benefits Companies

Sonrava Health has announced that it has entered into a strategic alliance with FCL Dental, […]

Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board

Johnson & Johnson has announced that its Board of Directors has elected CEO, Mr. Joaquin […]

Babyl & Novo Nordisk Partner to Provide an Innovative Approach to Diabetes Awareness and Care in Rwanda

Babyl, a subsidiary of Babylon, and Novo Nordisk announced today that they have entered an […]

BRIM Biotechnology Raises $20 Million in Series E Funding Round

BRIM Biotechnology, a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure […]

Monica Chopra Joins Auxa Health as Co-Founder & CEO

 Auxa Health, a leading social care orchestration technology company, announced Monica Chopra, MBA, MPH as its […]

UpStream and Tidewater Physicians Multispecialty Group Announce Partnership

UpStream, a value-based management services organization based in Greensboro, NC with a unique model of […]

PhRMA Foundation Announces New Members of Board of Directors

The PhRMA Foundation has announced the appointment to its Board of Directors of Aida Habtezion, MD, […]

Bryn Pharma Strengthens Board of Directors with Appointments of Commercial Veterans Sandy Loreaux and William D. Humphries

Bryn Pharma LLC, a privately held pharmaceutical company dedicated to finding a better way for […]

Turnstone Biologics Enters Cooperative Research and Development Agreement with the National Cancer Institute

Turnstone Biologics Corp, a clinical-stage biotechnology company developing next-generation immunotherapies to treat and cure solid […]

New Funding of $2 Million for Research Bringing Us One Step Closer to a Cure for Follicular Lymphoma

The Follicular Lymphoma Foundation (FLF) today announced it has awarded four research grants of up to […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more